CL2016000893A1 - Intrauterine administration system comprising a construction of a body and two deposits, which comprise a progestogen where the deposits have different rates and release times - Google Patents
Intrauterine administration system comprising a construction of a body and two deposits, which comprise a progestogen where the deposits have different rates and release timesInfo
- Publication number
- CL2016000893A1 CL2016000893A1 CL2016000893A CL2016000893A CL2016000893A1 CL 2016000893 A1 CL2016000893 A1 CL 2016000893A1 CL 2016000893 A CL2016000893 A CL 2016000893A CL 2016000893 A CL2016000893 A CL 2016000893A CL 2016000893 A1 CL2016000893 A1 CL 2016000893A1
- Authority
- CL
- Chile
- Prior art keywords
- deposits
- pdms
- progestogen
- administration system
- reservoir
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Sistema de administración intrauterina que comprende una construcción de cuerpo y dos depósitos donde el núcleo y la membrana consisten en un polímero con una composición idéntica o diferente donde los depósitos comprenden un progestágeno o un fármaco que presenta actividad progestagénica que se libera durante un periodo de tiempo prolongado, en un nivel requerido para la anticoncepción donde las velocidades de liberación y los tiempos de liberación de dichos deposito son diferentes donde la membrana que encierra el núcleo del depósito 1 está compuesta esencialmente por PDMS o por una mezcla polimérica de copolímeros en bloque de óxido de polietileno y PEO-b-PDMS o por una mezcla elastomérica de PTFPMS y PDMS, y donde la membrana que encierra el núcleo del depósito 2 comprende una mezcla de PTFPMS y PDMS.Intrauterine administration system comprising a body construction and two deposits where the core and membrane consist of a polymer with an identical or different composition where the deposits comprise a progestogen or a drug that has progestagenic activity that is released over a period of time. prolonged, at a level required for contraception where the release rates and release times of said reservoir are different where the membrane that encloses the core of the reservoir 1 is essentially composed of PDMS or a polymeric mixture of oxide block copolymers of polyethylene and PEO-b-PDMS or by an elastomeric mixture of PTFPMS and PDMS, and where the membrane that encloses the core of the reservoir 2 comprises a mixture of PTFPMS and PDMS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361893083P | 2013-10-18 | 2013-10-18 | |
| EP13397533 | 2013-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016000893A1 true CL2016000893A1 (en) | 2016-11-04 |
Family
ID=59018208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016000893A CL2016000893A1 (en) | 2013-10-18 | 2016-04-15 | Intrauterine administration system comprising a construction of a body and two deposits, which comprise a progestogen where the deposits have different rates and release times |
Country Status (2)
| Country | Link |
|---|---|
| CL (1) | CL2016000893A1 (en) |
| HK (1) | HK1221634A1 (en) |
-
2016
- 2016-04-15 CL CL2016000893A patent/CL2016000893A1/en unknown
- 2016-08-02 HK HK16109198.3A patent/HK1221634A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1221634A1 (en) | 2017-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018003425A1 (en) | Cannabidiol compositions and uses thereof. | |
| PE20160534A1 (en) | INTRAUTERINE ADMINISTRATION SYSTEM | |
| EP4360676A3 (en) | Autoinjector with an audible indicator | |
| CO2017007003A2 (en) | Sunitinib formulations and methods for using them in the treatment of eye disorders | |
| UY37341A (en) | FORMULATIONS OF GAMMA-MODIFIED RELEASE HYDROXIBUTIRATE WITH IMPROVED PHARMACOCINETICS | |
| WO2015069773A8 (en) | Devices and methods for continuous drug delivery via the mouth | |
| MX2017015599A (en) | Drug delivery device with audible indicator spring. | |
| CL2016001041A1 (en) | Biodegradable intraocular implant containing a biodegradable polymer matrix, polyethylene glycol 3350 and a prostamide; use thereof in reducing the eye pressure in the eye of a mammal; apparatus for administering the biodegradable intraocular implant; and method to make a biodegradable intraocular implant. | |
| BR112015022433A2 (en) | drug permeable drug delivery devices and methods | |
| CY1117969T1 (en) | ANTI-PSYCHOLOGICAL ADMINISTRATION OF LONG-TERM ACTION | |
| BR112015018095A2 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| CO2019000643A2 (en) | Oral gastro-retentive formulations and uses thereof | |
| CL2017002536A1 (en) | Injectable extended release formulations comprising an active isoxazoline agent, methods and uses thereof. | |
| BR112015027699A2 (en) | USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE | |
| BR112018003882A2 (en) | auxiliary material for providing drug elution from vessels | |
| BR112017005209A2 (en) | rorc2 methyl and trifluoromethyl substituted pyrrolopyridine modulating compounds and their use | |
| EA201690967A1 (en) | EYE DEVICE | |
| BR112018074135A2 (en) | absorbent article. | |
| DOP2017000307A (en) | ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME. | |
| CL2017001025A1 (en) | Compounds for use in anthelmintic treatment | |
| CY1121852T1 (en) | FORMULATIONS AND METHODS OF PREPARING FORMULATIONS FOR USE IN COLON CLEANSING | |
| AR094289A1 (en) | SYSTEMS OF TRANSDERMAL ADMINISTRATION OF PHARMACOS FOR LEVONORGESTREL AND ETINIL ESTRADIOL | |
| AR116501A1 (en) | LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED DRUG ADMINISTRATION | |
| EA201991287A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS BASED ON TIKAGRELOR FOR ORAL USE | |
| SG10201902407PA (en) | Injectable microparticles for hyper-localized release of therapeutic agents |